Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution

DUBLIN, Feb. 17, 2017 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE, TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide or... Biopharmaceuticals, Generics, FDA Perrigo Company, Hydrocodone, homatropine

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2042163

Source: HSMN NewsFeed - February 17, 2017 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Hydrocodone | Marketing | Pharmaceuticals